Pfizer Admits Defeat for Now: Kulhoff

Pfizer Admits Defeat for Now: Kulhoff Play

May 26 (Bloomberg) -- Birgit Kulhoff, Heath Care Analyst at Rahn & Bodmer, discusses the likelihood of a deal between Pfizer and AstraZeneca, and what that may mean for cancer, diabetes, and auto immune disease drugs. She speaks on Bloomberg Television's “The Pulse.” (Source: Bloomberg)

  • On Air Now

    Street Smart with Trish Regan Watch Now

  • Next

    Taking Stock with Pimm Fox

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus